189 filings
Page 4 of 10
6-K
3sylbn4qtdf4t jgws
27 Dec 22
Current report (foreign)
6:05am
6-K
btk6d 83mm9
21 Dec 22
NANOBIOTIX Announces Termination of Liquidity Contract and Publishes End of Contract Statement
4:15pm
6-K
k85b ftb925
8 Dec 22
Voting Rights and Shares Capital of the Company
4:15pm
6-K
3gz4mv cpsbfs7eu68
15 Nov 22
NANOBIOTIX to Present at the 5th Annual Evercore ISI HealthCONx Conference
4:15pm
6-K
ent vbl526
14 Nov 22
NANOBIOTIX Announces Recommended Phase 2 Dose for NBTXR3 in Pancreatic Cancer
4:17pm
6-K
x0y4998wek8zbh1r
10 Nov 22
Current report (foreign)
6:00am
6-K
kyvo7no
9 Nov 22
NANOBIOTIX Provides Third Quarter 2022 Operational and Financial Update
4:15pm
6-K
ij9t6rcfmb 36ilmbsw
8 Nov 22
NANOBIOTIX Voting Rights and Shares Capital of the Company
4:15pm
6-K
px0 slc3xl
2 Nov 22
NANOBIOTIX Appoints Renowned Global Experts to Comprehensive Scientific Advisory Board for Potential First-in-Class Radioenhancer NBTXR3
4:15pm
6-K
etudekw0u1rl
31 Oct 22
NANOBIOTIX to Present at the Jefferies London Healthcare Conference
4:15pm
6-K
bn3 qm0mjqkc9ux5
27 Oct 22
Current report (foreign)
4:15pm
6-K
cj6aoc6re5y ak
18 Oct 22
NANOBIOTIX Executes Definitive Agreement to Restructure Existing Loan With the European Investment Bank
4:15pm
6-K
y4v dg3h1stl6
11 Oct 22
Nanobiotix S.a. 6-K
9:21am
6-K
gtfqi7z7ftugj2mg
28 Sep 22
Nanobiotix S.a. 6-K
4:56pm
6-K
7y8 wapmi
28 Sep 22
Current report (foreign)
4:52pm
6-K
u8azke
22 Sep 22
Nanobiotix S.a. 6-K
4:17pm
6-K
y9zpj34 29ax4
21 Sep 22
Nanobiotix S.a. 6-K
4:16pm
6-K
8p5gcradvdcx
12 Sep 22
Nanobiotix S.a. 6-K
6:01am
6-K
96cd9d7fs auh
8 Sep 22
Nanobiotix S.a. 6-K
4:15pm
6-K
fr1eh
7 Sep 22
Nanobiotix S.a. 6-K
4:15pm